Casado-Suela, M.Á.; Torres-Macho, J.; Prada-Alonso, J.; Pastorín-Salis, R.; Martínez de la Casa-Muñoz, A.; Ruiz-Navío, E.; Bustamante-Fermosel, A.; Franco-Moreno, A.
Use of Radiomics to Predict Adverse Outcomes in Patients with Pulmonary Embolism: A Scoping Review of an Unresolved Clinical Challenge. Diagnostics 2025, 15, 2022.
https://doi.org/10.3390/diagnostics15162022
AMA Style
Casado-Suela MÁ, Torres-Macho J, Prada-Alonso J, Pastorín-Salis R, Martínez de la Casa-Muñoz A, Ruiz-Navío E, Bustamante-Fermosel A, Franco-Moreno A.
Use of Radiomics to Predict Adverse Outcomes in Patients with Pulmonary Embolism: A Scoping Review of an Unresolved Clinical Challenge. Diagnostics. 2025; 15(16):2022.
https://doi.org/10.3390/diagnostics15162022
Chicago/Turabian Style
Casado-Suela, Miguel Ángel, Juan Torres-Macho, Jesús Prada-Alonso, Rodrigo Pastorín-Salis, Ana Martínez de la Casa-Muñoz, Eva Ruiz-Navío, Ana Bustamante-Fermosel, and Anabel Franco-Moreno.
2025. "Use of Radiomics to Predict Adverse Outcomes in Patients with Pulmonary Embolism: A Scoping Review of an Unresolved Clinical Challenge" Diagnostics 15, no. 16: 2022.
https://doi.org/10.3390/diagnostics15162022
APA Style
Casado-Suela, M. Á., Torres-Macho, J., Prada-Alonso, J., Pastorín-Salis, R., Martínez de la Casa-Muñoz, A., Ruiz-Navío, E., Bustamante-Fermosel, A., & Franco-Moreno, A.
(2025). Use of Radiomics to Predict Adverse Outcomes in Patients with Pulmonary Embolism: A Scoping Review of an Unresolved Clinical Challenge. Diagnostics, 15(16), 2022.
https://doi.org/10.3390/diagnostics15162022
